Serum IGF-1 expression levels were higher in patients with early PD [63] than in patients in the middle and late stages, indicating that serum IGF-1 levels are significantly negatively correlated with anxiety, depression, and cognitive impairment [63, 64]. The gene discussed is IGF1; the disease is Parkinson disease.